FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC.

Details

Language :

English

ISSN :

15560864

Volume :

13

Issue :

11

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

132606121

Full Text :

https://doi.org/10.1016/j.jtho.2018.05.004